We are live on ! Find out more
EA

Evolution Advisers Portfolio holdings

AUM $272M Turnover 83.51%
1-Year Est. Return 14.96%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+14.96%
3 Year Est. Return
+40.78%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$272M
AUM Growth
+$34.8M
Cap. Flow
+$14M
Cap. Flow %
5.13%
Top 10 Hldgs %
79.72%
Holding
946
New
786
Increased
86
Reduced
12
Closed
4
Avg Time Held
0.6 years
Top 10 Avg Time Held
4.5 years
Top 20 Avg Time Held
3.9 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 95.93%
2 Financials 1.31%
3 Technology 0.91%
4 Industrials 0.44%
5 Communication Services 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PRDO icon
726
Perdoceo Education
PRDO
$2.11B
$0 ﹤0.01%
+5
New +$171
2026 Q2
0 quarters
PRGS icon
727
Progress Software
PRGS
$1.67B
$0 ﹤0.01%
+8
New +$237
2026 Q2
0 quarters
PRG icon
728
PROG Holdings
PRG
$1.23B
$0 ﹤0.01%
+9
New +$314
2026 Q2
0 quarters
PRGO icon
729
Perrigo
PRGO
$2.31B
$0 ﹤0.01%
+26
New +$286
2026 Q2
0 quarters
PRLB icon
730
Protolabs
PRLB
$2.05B
$0 ﹤0.01%
+2
New +$141
2026 Q2
0 quarters
PRVA icon
731
Privia Health
PRVA
$2.88B
$0 ﹤0.01%
+9
New +$208
2026 Q2
0 quarters
PSMT icon
732
Pricesmart
PSMT
$5.24B
$0 ﹤0.01%
+3
New +$500
2026 Q2
0 quarters
PTCT icon
733
PTC Therapeutics
PTCT
$4.94B
$0 ﹤0.01%
+5
New +$361
2026 Q2
0 quarters
PTEN icon
734
Patterson-UTI
PTEN
$4.39B
$0 ﹤0.01%
+37
New +$413
2026 Q2
0 quarters
PTGX icon
735
Protagonist Therapeutics
PTGX
$8.33B
$0 ﹤0.01%
+5
New +$522
2026 Q2
0 quarters
PZZA icon
736
Papa John's
PZZA
$638M
$0 ﹤0.01%
+3
New +$104
2026 Q2
0 quarters
QCOM icon
737
Qualcomm
QCOM
$184B
$0 ﹤0.01%
+3
New +$561
2026 Q2
0 quarters
QDEL icon
738
QuidelOrtho
QDEL
$885M
$0 ﹤0.01%
+10
New +$132
2026 Q2
0 quarters
QNST icon
739
QuinStreet
QNST
$934M
$0 ﹤0.01%
+7
New +$88
2026 Q2
0 quarters
QRVO icon
740
DELISTED
Qorvo
QRVO
$0 ﹤0.01%
+8
New +$738
2026 Q2
0 quarters
RAMP icon
741
LiveRamp
RAMP
$2.28B
$0 ﹤0.01%
+14
New +$461
2026 Q2
0 quarters
RCUS icon
742
Arcus Biosciences
RCUS
$2.82B
$0 ﹤0.01%
+18
New +$445
2026 Q2
0 quarters
RDN icon
743
Radian Group
RDN
$4.5B
$0 ﹤0.01%
+17
New +$603
2026 Q2
0 quarters
RDNT icon
744
RadNet
RDNT
$5.41B
$0 ﹤0.01%
+6
New +$337
2026 Q2
0 quarters
REG icon
745
Regency Centers
REG
$13.4B
$0 ﹤0.01%
+2
New +$157
2026 Q2
0 quarters
RELY icon
746
Remitly
RELY
$5.11B
$0 ﹤0.01%
+14
New +$287
2026 Q2
0 quarters
RES icon
747
RPC Inc
RES
$1.34B
$0 ﹤0.01%
+19
New +$132
2026 Q2
0 quarters
REX icon
748
REX American Resources
REX
$1.38B
$0 ﹤0.01%
+19
New +$879
2026 Q2
0 quarters
REZI icon
749
Resideo Technologies
REZI
$2.5B
$0 ﹤0.01%
+15
New +$516
2026 Q2
0 quarters
RHI icon
750
Robert Half
RHI
$3.41B
$0 ﹤0.01%
+4
New +$112
2026 Q2
0 quarters

Similar funds

Evolution Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, Evolution Advisers held 946 positions worth $272M, up 15% from $237M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Evolution Advisers deployed $14M of net new capital in Q2 2026, opening 786 new positions and adding to 86 existing holdings. Its largest new stake was Schwab Fundamental International Large Company Index ETF: 9,453 shares worth $498K.

By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, up from 96% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares Core International Aggregate Bond Fund, an estimated $3.46M trimmed.

  • Evolution Advisers's largest Q2 2026 buy was Schwab Fundamental International Large Company Index ETF: 9,453 shares worth $498K.
  • Evolution Advisers added most to Vanguard Total International Bond ETF in Q2 2026, an estimated $4.91M increase.
  • Evolution Advisers's biggest Q2 2026 reduction was iShares Core International Aggregate Bond Fund, cutting an estimated $3.46M.
  • Evolution Advisers fully exited ExxonMobil in Q2 2026, selling an estimated $838K.
  • Evolution Advisers's ten largest holdings make up 80% of its $272M portfolio in Q2 2026.
  • Evolution Advisers opened 786 new positions and closed 4 in Q2 2026.
  • Evolution Advisers's portfolio value rose 15% quarter-over-quarter to $272M.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.